Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
54 studies found for:    "Lewy body dementia"
Show Display Options
Rank Status Study
1 Completed Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Condition: Lewy Body Dementia
Intervention: Procedure: Single photon emission computed tomography and Magnetic Resonance Imaging
2 Recruiting Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Visual Hallucinations
Interventions: Drug: Nelotanserin;   Drug: Placebo
3 Unknown  Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))
Conditions: Alzheimer's Disease;   Lewy Body's Dementia
Interventions: Other: Rey figure test;   Other: MRI
4 Completed Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
Condition: Lewy Body Disease
Intervention: Drug: Galantamine
5 Recruiting Effects of Nucleus Basalis of Meynert Stimulation on Cognitive Disorders in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Intervention: Procedure: Electrical stimulation of the nucleus basalis of Meynert
6 Completed Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: Donepezil
7 Completed
Has Results
"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"
Condition: Dementia With Lewy Bodies
Intervention: Drug: Armodafinil
8 Recruiting Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study
Condition: Dementia With Lewy Bodies
Interventions: Drug: RVT-101 35 mg;   Drug: RVT-101 70 mg;   Drug: Placebo
9 Enrolling by invitation Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
Condition: Dementia With Lewy Bodies
Interventions: Drug: RVT-101 35 mg;   Drug: RVT-101 70 mg
10 Completed Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Other: Imaging with IBVM;   Other: Imaging with DATSCAN;   Behavioral: neuropsychological evaluation
11 Completed Deep Brain Stimulation for Patients With Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Procedure: Bilateral Nucleus Basalis Meynert DBS;   Procedure: Sham Nucleus Basalis Meynert DBS
12 Recruiting Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
Condition: Dementia With Lewy Body Disease
Intervention: Drug: Donepezil Hydrochloride
13 Completed
Has Results
A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: E2020
14 Completed
Has Results
A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: 3 mg Donepezil hydrochloride;   Drug: 5 mg Donepezil hydrochloride;   Drug: 10 mg Donepezil hydrochloride;   Drug: Placebo
15 Completed
Has Results
A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: Donepezil 5 mg;   Drug: Donepezil 10 mg;   Drug: Donepezil matched placebo
16 Unknown  Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
Condition: "Alzheimer's Disease" and "Lewy Body Disease"
Interventions: Other: MRI;   Procedure: lumbar puncture;   Behavioral: neuropsychological tests
17 Recruiting A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
Conditions: Dementia, Lewy Body;   Lewy Body Disease
Interventions: Drug: E2020;   Drug: Placebo
18 Completed A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Condition: Lewy Body Disease
Intervention: Drug: Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)
19 Completed Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
Conditions: Parkinson's Disease Dementia;   Dementia With Lewy Bodies
Interventions: Drug: Memantine;   Drug: Placebo
20 Enrolling by invitation Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Conditions: Lewy Body Dementia;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia;   Visual Hallucinations;   REM Sleep Behavior Disorder
Intervention: Drug: Nelotanserin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.